149 related articles for article (PubMed ID: 20717634)
1. [Sphingomyelin synthase 2 deficiency decreases atherosclerosis and inhibits inflammation in mice].
Qin R; Chen ML; Zhu K; Deng JB; Shi YY
Sheng Li Xue Bao; 2010 Aug; 62(4):333-8. PubMed ID: 20717634
[TBL] [Abstract][Full Text] [Related]
2. Macrophage sphingomyelin synthase 2 deficiency decreases atherosclerosis in mice.
Liu J; Huan C; Chakraborty M; Zhang H; Lu D; Kuo MS; Cao G; Jiang XC
Circ Res; 2009 Jul; 105(3):295-303. PubMed ID: 19590047
[TBL] [Abstract][Full Text] [Related]
3. Sphingomyelin synthase 2 is one of the determinants for plasma and liver sphingomyelin levels in mice.
Liu J; Zhang H; Li Z; Hailemariam TK; Chakraborty M; Jiang K; Qiu D; Bui HH; Peake DA; Kuo MS; Wadgaonkar R; Cao G; Jiang XC
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):850-6. PubMed ID: 19286635
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus-mediated sphingomyelin synthase 2 increases atherosclerotic lesions in ApoE KO mice.
Wang X; Dong J; Zhao Y; Li Y; Wu M
Lipids Health Dis; 2011 Jan; 10():7. PubMed ID: 21235823
[TBL] [Abstract][Full Text] [Related]
5. Sphingomyelin synthase 2 deficiency attenuates NFkappaB activation.
Hailemariam TK; Huan C; Liu J; Li Z; Roman C; Kalbfeisch M; Bui HH; Peake DA; Kuo MS; Cao G; Wadgaonkar R; Jiang XC
Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1519-26. PubMed ID: 18566297
[TBL] [Abstract][Full Text] [Related]
6. Selective reduction in the sphingomyelin content of atherogenic lipoproteins inhibits their retention in murine aortas and the subsequent development of atherosclerosis.
Fan Y; Shi F; Liu J; Dong J; Bui HH; Peake DA; Kuo MS; Cao G; Jiang XC
Arterioscler Thromb Vasc Biol; 2010 Nov; 30(11):2114-20. PubMed ID: 20814016
[TBL] [Abstract][Full Text] [Related]
7. Sphingomyelin synthase 2 over-expression induces expression of aortic inflammatory biomarkers and decreases circulating EPCs in ApoE KO mice.
Zhao YR; Dong JB; Li Y; Wu MP
Life Sci; 2012 Jun; 90(21-22):867-73. PubMed ID: 22538014
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of sphingomyelin synthase (SMS) affects intracellular sphingomyelin accumulation and plasma membrane lipid organization.
Li Z; Hailemariam TK; Zhou H; Li Y; Duckworth DC; Peake DA; Zhang Y; Kuo MS; Cao G; Jiang XC
Biochim Biophys Acta; 2007 Sep; 1771(9):1186-94. PubMed ID: 17616479
[TBL] [Abstract][Full Text] [Related]
9. Sphingomyelin Synthase 2 Inhibition Ameliorates Cerebral Ischemic Reperfusion Injury Through Reducing the Recruitment of Toll-Like Receptor 4 to Lipid Rafts.
Xue J; Yu Y; Zhang X; Zhang C; Zhao Y; Liu B; Zhang L; Wang L; Chen R; Gao X; Jiao P; Song G; Jiang XC; Qin S
J Am Heart Assoc; 2019 Nov; 8(22):e012885. PubMed ID: 31718447
[TBL] [Abstract][Full Text] [Related]
10. Prenatal alcohol exposure inducing the apoptosis of mossy cells in hippocampus of SMS2-/- mice.
Wang L; Wu L; Wang X; Deng J; Ma Z; Fan W; He W; Deng J
Environ Toxicol Pharmacol; 2015 Nov; 40(3):975-82. PubMed ID: 26562048
[TBL] [Abstract][Full Text] [Related]
11. Discovery, synthesis and anti-atherosclerotic activities of a novel selective sphingomyelin synthase 2 inhibitor.
Li Y; Huang T; Lou B; Ye D; Qi X; Li X; Hu S; Ding T; Chen Y; Cao Y; Mo M; Dong J; Wei M; Chu Y; Li H; Jiang XC; Cheng N; Zhou L
Eur J Med Chem; 2019 Feb; 163():864-882. PubMed ID: 30580239
[TBL] [Abstract][Full Text] [Related]
12. Sphingomyelin synthase 2 (SMS2) deficiency attenuates LPS-induced lung injury.
Gowda S; Yeang C; Wadgaonkar S; Anjum F; Grinkina N; Cutaia M; Jiang XC; Wadgaonkar R
Am J Physiol Lung Cell Mol Physiol; 2011 Mar; 300(3):L430-40. PubMed ID: 21191108
[TBL] [Abstract][Full Text] [Related]
13. Dynamic modification of sphingomyelin in lipid microdomains controls development of obesity, fatty liver, and type 2 diabetes.
Mitsutake S; Zama K; Yokota H; Yoshida T; Tanaka M; Mitsui M; Ikawa M; Okabe M; Tanaka Y; Yamashita T; Takemoto H; Okazaki T; Watanabe K; Igarashi Y
J Biol Chem; 2011 Aug; 286(32):28544-55. PubMed ID: 21669879
[TBL] [Abstract][Full Text] [Related]
14. Adenovirus-mediated overexpression of sphingomyelin synthases 1 and 2 increases the atherogenic potential in mice.
Dong J; Liu J; Lou B; Li Z; Ye X; Wu M; Jiang XC
J Lipid Res; 2006 Jun; 47(6):1307-14. PubMed ID: 16508036
[TBL] [Abstract][Full Text] [Related]
15. Imaging Mass Spectrometry Reveals Acyl-Chain- and Region-Specific Sphingolipid Metabolism in the Kidneys of Sphingomyelin Synthase 2-Deficient Mice.
Sugimoto M; Wakabayashi M; Shimizu Y; Yoshioka T; Higashino K; Numata Y; Okuda T; Zhao S; Sakai S; Igarashi Y; Kuge Y
PLoS One; 2016; 11(3):e0152191. PubMed ID: 27010944
[TBL] [Abstract][Full Text] [Related]
16. Sphingomyelin synthase 2 deficiency inhibits the induction of murine colitis-associated colon cancer.
Ohnishi T; Hashizume C; Taniguchi M; Furumoto H; Han J; Gao R; Kinami S; Kosaka T; Okazaki T
FASEB J; 2017 Sep; 31(9):3816-3830. PubMed ID: 28522594
[TBL] [Abstract][Full Text] [Related]
17. Impact of sphingomyelin synthase 1 deficiency on sphingolipid metabolism and atherosclerosis in mice.
Li Z; Fan Y; Liu J; Li Y; Huan C; Bui HH; Kuo MS; Park TS; Cao G; Jiang XC
Arterioscler Thromb Vasc Biol; 2012 Jul; 32(7):1577-84. PubMed ID: 22580896
[TBL] [Abstract][Full Text] [Related]
18. Possible roles of long-chain sphingomyelines and sphingomyelin synthase 2 in mouse macrophage inflammatory response.
Sakamoto H; Yoshida T; Sanaki T; Shigaki S; Morita H; Oyama M; Mitsui M; Tanaka Y; Nakano T; Mitsutake S; Igarashi Y; Takemoto H
Biochem Biophys Res Commun; 2017 Jan; 482(2):202-207. PubMed ID: 27836537
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the role of sphingomyelin synthase 2 in glucose metabolism in whole-body and peripheral tissues in mice.
Sugimoto M; Shimizu Y; Zhao S; Ukon N; Nishijima K; Wakabayashi M; Yoshioka T; Higashino K; Numata Y; Okuda T; Tamaki N; Hanamatsu H; Igarashi Y; Kuge Y
Biochim Biophys Acta; 2016 Aug; 1861(8 Pt A):688-702. PubMed ID: 27151272
[TBL] [Abstract][Full Text] [Related]
20. Epidermal permeability barrier function and sphingolipid content in the skin of sphingomyelin synthase 2 deficient mice.
Nomoto K; Itaya Y; Watanabe K; Yamashita T; Okazaki T; Tokudome Y
Exp Dermatol; 2018 Aug; 27(8):827-832. PubMed ID: 29345004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
